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ABSTRACT: Scalable immunoassay multiplexing oﬀers a route to creating
rapid point-of-care (POC) diagnostics. We present a method for
multiplexing immunoassays on the surface of a complementary metal
oxide semiconductor (CMOS) sensor array integrated circuit (IC) without
the use of physical separators such as wells or channels. Major advantages of
using a CMOS sensor array include low mass-manufacturing costs, the
possibility to multiplex multiple assays on a single IC, and improved signal
when averaging multiple sensors, along with providing a platform where
wash steps can be incorporated to maximize selectivity and sensitivity
compared to paper based lateral ﬂow immunoassay. The device was able to
diﬀerentiate between samples containing either, neither, or both rabbit anti-mouse (RAM) antibodies and/or anti-HIV gp120
antibodies in serum using a gold-nanoparticle promoted silver enhancement immunoassay. HIV antibody concentrations down
to 100 μg/mL were readily detected, which is three times lower than those typically found in infected humans (300−500 μg/
mL), and the limit of detection was 10 μg/mL.
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Many medical tests are invasive, time-consuming, andusually require specialist medical centers. A time-lag
therefore ensues while samples are analyzed remotely, and a
repeat visit to the medical center is required to discuss
outcomes. Furthermore, the ability to home-test for various
diseases has improved the ability for rapid diagnosis and
implementation of appropriate medical intervention. Home
pregnancy testing represents the prime example.1,2 A hand-held
device not only increases convenience but also oﬀers
diagnostics in remote areas where laboratory tests are not
locally available.
The usefulness of mobile phones in health care has already
been demonstrated.3−9 Testing for a multitude of substances
that are indicative of disease could be done using devices that
link to a smartphone and measure analytes within a drop of
blood. The work presented here provides a step in that
direction through detection of anti-HIV and rabbit anti-mouse
(RAM) antibodies on a hand-held chip-based device (Figure 1).
The HIV assay used in this paper has been proven to work with
whole blood.10
Antibodies are soluble proteins that circulate in blood and
bind speciﬁcally to foreign molecules (antigens) as part of the
adaptive immune response.11 Antibodies are frequently
exploited in immunoassays for diagnostic purposes as their
production is in direct response to the presence of foreign
antigens in the host system. In a direct immunoassay, the
presence of the disease (antigen) is detected using exogenous
antibodies speciﬁc to the antigen. In an indirect immunoassay,
it is the presence of an antibody to a speciﬁc disease (antigen)
that is detected (immune response). It is much easier to detect
antibodies due to their abundance,12−14 although the body
needs some time to produce antibodies after being infected (a
process termed seroconversion).
Complementary metal oxide semiconductor (CMOS)
technology has revolutionized the microelectronic industry,
being both low-cost and reliable. In this paper, we demonstrate
concurrent, interference-free execution of two optical immuno-
assays on the surface of a CMOS sensor array chip to detect
antibodies targeted to the immunodominant gp120 antigen of
HIV, and also antibodies to a second antigen (mouse IgG),
demonstrating the potential to develop a multiplexed assay
system on the surface of a CMOS sensor array.
Multiple analyte detection is the key to creating a useful
health diagnostic device. A proof of concept sandwich
immunoassay was developed to demonstrate the functionality
of a phone-CMOS platform. In the RAM assay, rabbit anti-
mouse antibodies bind to printed mouse antibodies on the
surface of the chip. These antibodies are detected with gold-
labeled goat anti-rabbit antibodies.
This assay can be easily modiﬁed to detect useful real world
analytes such as antibodies to HIV, syphilis, hepatitis, malaria,
West Nile virus, Chagas disease, herpes, and Zika. The
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technology presented can be adopted to create a single
diagnostic chip, for example, that corresponds to all sexually
transmitted diseases or pathogens known to cause fever in
tropical settings. As it is often hard to ascertain the cause of
fever in tropical areas, such a tool would be invaluable. In the
assays presented here, droplets of the assay solution were
manually printed onto the chip using a polystyrene needle.
However, other technologies exist capable of printing much
smaller droplets, which in turn would increase the number of
assays available on a chip.15,16
HIV was chosen for demonstration as it remains a major
global public health issue, having claimed more than 35 million
lives so far. It is estimated, however, that only 54% of people
with HIV know their status (WHO facts, 2016). Including HIV
testing on any personal health diagnostic tool is extremely
important. While rapid HIV testing already exists17−19 our
ultimate aim is to integrate HIV testing with other assays into a
single device. Having an HIV test in a personal health machine
would be beneﬁcial as it would increase the convenience,
privacy and reach of HIV testing. Being easy, low-cost, and
anonymous, it could be used in areas where conventional
testing is not available.
Immunoassay formats reported in refs 10 and 20 allow
multiple assays to be performed on the surface of a single chip
where diﬀerent proteins can be positioned with precision on
the chip surface. The assay then uses changes in the absorption
of light applied to the surface allowing detection with a
photodiode. The sensitivity of the silver-ampliﬁed immunoassay
reported in ref 10 rivals that of the gold standard laboratory-
based HIV ELISA tests, but also includes antigens capable of
detecting seroconversion to syphilis. A polystyrene microﬂuidic
cassette, with individual detectors for each assay, thus oﬀers a
system that can detect HIV and syphilis in a drop of blood,
using a smartphone accessory. While proving the ability to
make multiple assays on a single chip, scaling up the total
number of possible assays is restricted by engineering
requirements for the microﬂuidic cassettes.
A major advantage of using silicon CMOS technology is that
it readily allows for miniaturization so that multiple sensors can
be cointegrated at low cost. Furthermore, the ability to
integrate electronic functionality such as signal ampliﬁcation
and data multiplexing from an array of sensors enables new
multiple assay technologies to be realized. While CMOS
possesses many of the required attributes of a biosensor
technology, a certain amount of post-processing (back-end of
line) is necessary, and we show how a readily available epoxy
based photoresist used for microelectro-mechanical systems,
SU-8, can be exploited to facilitate assay immobilization
technology, making multiple assays on a single chip possible.
The combination of CMOS and immobilization technologies
allows qualitative analysis from multiple assays simultaneously
with the sensitivity needed to measure physiological levels of
antibodies found for many diseases in human blood.
The CMOS array presented has 256 sensors. With
suﬃciently advanced inkjet printing technology, each couple
of sensors can be functionalized to perform diﬀerent immuno-
assays. Even with the manual printing technique used in this
work, up to six droplets were printed on a single chip with
functioning antibodies. However, there are only three distinct
biological assays presented here (including the control).
■ RESULTS AND DISCUSSION
Instrumentation and Measurement System. An ARM
mbed data acquisition platform was assembled that can be
connected to a smartphone/PC via USB or Bluetooth (Figure
1C−D). An Android app was created to evaluate the usefulness
of a smartphone connected blood testing device.
Once the chip was packaged and processed and the
immunoassay was executed, the chip was inserted into a PGA
ZIF socket attached to a custom printed circuit board
(Newbury Electronics, UK) designed to connect the chip
Figure 1. Immunoassay capable smartphone accessory. Images showing the construction of the CMOS chip carrier (A, B) and data acquisition
electronics (C) which can be connected to a smartphone or a PC (D). The CMOS chip carrier ﬁts into the socket on the chip PCB. An LED and
cover and mounted on top of the chip PCB. On the other side of the chip PCB there are sockets to plug in the mbed (ST-Nucleo) board which
handles the data acquisition and communication with the smartphone/PC. The smartphone app is shown displaying the acquired data in visual and
numerical form. Colored crosses can be moved around to choose the individual pixels being charted.
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carrier to the COTS mbed board (NUCLEO-F334R8,
STMicroelectronics).
An external power supply was used to power the chip during
all experiments presented. However, USB OTG was used to
power and communicate with the entire system during
smartphone connected trials.
Initial experiments to verify the chip and the assay were
conducted with the platform attached to a PC, but as the
technology matured we connected the platform to a
smartphone to fulﬁll our objective. The USB serial interface
of the mbed board was used for communication. First, the PC/
smartphone sends a command byte to the mbed, and then the
mbed sends back 256 bytes, each corresponding to a pixel
readout. The bytes are counted to make sure no data loss
occurred and then presented on the screen. Also, all the data is
streamed to permanent storage using the CSV ﬁle format or, in
the case of LabView, the National Instruments TDMS ﬁle
format. Reading an entire frame in this way takes less than 100
ms. The serial bus is set to run at 115 200 baud.
The mbed measures the voltage output of each pixel with the
use of its analog to digital converter (ADC). It iterates through
all the pixels in the array by outputting their digital addresses in
sequence. Once a valid address is presented, the voltage output
of the corresponding pixel appears on the analog output pin. It
sends all the acquired data through its serial interface.
The USB OTG connected android acquisition app
developed surpassed the PC based LabView VI in both stability
and speed. Another advantage of a wired (not Bluetooth)
smartphone accessory is that it does not need its own power
source. The android app is available for download in the
Google Play store under “Multicorder USB”.
Experimental Results. Antibody detection was chosen
over antigen detection in this study (Figure 2) because of the
relative ease of detection of antibodies in seroconverted
blood.12,13 However, sandwich assays using a bait antibody to
capture proteins from serum, which can then be detected using
a second antibody, this time gold nanoparticle labeled, would
be equally useful with this same setup.
A positive response results in the appearance of dark spots at
positions where the corresponding proteins were printed.
Otherwise, the image is homogeneous. Spectral transmission of
the silver spots was measured with a spectrophotometer to aid
in the choice of an LED emitting light at the correct
wavelength, although there was no signiﬁcant practical
advantage of using one color over the other. The system we
present is analogous to an ELISA type assay but miniaturized
and amenable to simple electronic readout using a smartphone.
The sensor chips were fully characterized before performing the
experiments.
The sensor array was functionalized by the addition of
droplets containing diﬀerent proteins, including the HIV gp120
protein and the mouse IgG (Figure 3A,B). The droplets were
printed manually with a polystyrene needle. The antigens
dissolved in the droplets adhered to the surface via direct
physisorption. Once the chip was functionalized and washed,
the entire chip was treated with BSA blocking buﬀer to avoid
nonspeciﬁc antibody binding. Antibodies speciﬁc to these
proteins were then added and nonspeciﬁcally bound antibody
washed from the chip surface. Nanogold-labeled secondary
antibodies were then added to bind to those primary sera and
these caused the precipitation of added silver within their direct
vicinity when this later reagent was added. The precipitation
masks photons from the LED from reaching the photodiode
detectors at the CMOS surface and the increase in absorbance
is detected electronically.
Once the assay was complete, the chip was dried and inserted
into the measurement system and the incident light on the
printed areas was measured and plotted with data from the
negative control areas which remained transparent. Experi-
ments were repeated at least three times on diﬀerent devices
with similar results. Run-to-run variation that can occur with
the illumination system in our prototype was compensated for
in the data presentation by graphing the diﬀerence between
control and active areas over many experiments (Figure 3C).
Figure 3D shows the results of positive and negative HIV and
rabbit anti-mouse (RAM) tests in serum printed on the surface
of the SU-8 coated chip. For each of these experiments, two
droplets were printed on the surface: one for the HIV and one
for the RAM assay. The printed surfaces only turned dark if the
test was positive; that is, antibody speciﬁc for the target antigen
was present in the serum. Negative control (HIV-/RAM-)
experiments were executed with the same analyte solution
(rabbit serum) but without the addition of the target antibody.
The data clearly demonstrates that the system can make two
separate assay measurements concurrently on the same chip,
without interference. The data we obtained was of suﬃciently
high quality to enable automated electronic threshold analysis
to determine the diagnostic outcome.
It can be seen that the voltage diﬀerence between positive
and negative control areas was 0.16 V for HIV and 0.36 V for
RAM, on average. The lowest diﬀerence we observed for a
positive HIV assay was 0.1 V while the largest diﬀerence
between negative control areas was 0.07 V. The achievable
Figure 2. Drawings showing the biochemical construction of the HIV
and the RAM assay. These assays are built step by step on the surface
of the chip with washes in between each step. The aim is to detect the
presence of HIV antibodies and/or anti-mouse rabbit (RAM)
antibodies in rabbit serum independent of each other, concurrently,
in the same sample solution. [1] The chip is covered with SU-8
photoresist. [2] Two droplets are printed on the surface of the chip:
one containing HIV gp120 antigen and one containing mouse IgG
(both in bicarbonate buﬀer, 10 μg/mL). Next, the chip is covered with
[3] BSA blocking buﬀer (PBS, 1%), [4] rabbit serum containing either,
both, or neither anti-HIV gp120 rabbit antibodies and anti-mouse
rabbit (RAM) antibodies (this is the analyte, 100 μg/mL, 65% rabbit
serum, PBS), [5] gold conjugated anti-rabbit antibody (A520 = 0.1),
[6] silver nitrate/hydroquinone solution (citrate buﬀer).
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electronic limit of detection is set by the supply voltage (3.3 V)
and the number of bits of the analog to digital converter (8) to
be 0.01 V. The data are therefore considerably larger than the
errors we determined from the system; hence, we estimate that
any assay that produces a voltage diﬀerence of more than 0.09
V can be considered positive.
_ = −Result HIV avg(HIV pixels) avg(CNT1 pixels)
_ = −Result RAM avg(RAM pixels) avg(CNT2 pixels)
σ=
√N
Error
The results of Figure 3D were obtained by using the
averaging capabilities from multiple independent pixels
provided by the photodiode sensor array: antigen droplets
were printed on the surface such that each droplet covered N =
9−30 sensors (Figure 3B). The signal standard deviation is
reduced by √N, where N is the number of sensors. When the
data was acquired the location of these pixel clusters were
known, using optical microscopy, and used to produce an
averaged result. Negative control areas were also chosen and,
again, the average signal from the cluster of pixels was taken.
Antibodies tended to concentrate at the edges of the droplet,
and so the edges became darker than the middle (coﬀee ring
eﬀect21). By averaging the entire area covered by the droplets,
false negative results could be avoided. The analyte (HIV gp120
antibody, anti-mouse rabbit antibody) concentration detected
was 100 μg/mL in rabbit serum (65%) diluted with PBS. The
detection part of the assay took 45 min (analyte incubation,
gold labeled antibody incubation, silver development).
In order to characterize the assays in depth, the parameter
space for all of the reagents and the reaction time was studied.
A complementary set of experiments was conducted on
polystyrene, the same material that is used for ELISA plates,
the current gold standard in immunoassays. Polystyrene slides
were placed on top of the CMOS chip. The CMOS chip was
masked by a cover with a small hole in the middle, focusing
light to the area of interest in the polystyrene slide. The entire
photodiode array was averaged in this case, so the chip
functioned as an ELISA plate reader. The assay referred to as
positive control (rabbit IgG) assay is a simpler version of the
RAM assay: gold conjugated anti-rabbit IgG binds to the
printed rabbit IgG on the surface.
Figure 3. Multiplexed HIV/RAM assay results in serum on CMOS chip with SU-8 surface. (Serum was diluted with water 65:35, data acquisition
system was connected to a smartphone.) (A) Typical size and position of printed droplets. HIV gp-120 antigen solution on the top left, mouse IgG
solution on the bottom right. (B) The epoxy walls and the misalignment of the illumination create a background gradient signal. To correct for this,
each printed droplet has a corresponding control area in the same column. While measurements of the chip before carrying out the assay provide
some control data, by measuring control pixels on the chips after the assay is done more faithfully enables accurate interpretation of the data. (C)
The diﬀerence in the printed and control area signals can be used to chart diﬀerent experiments (executed on diﬀerent devices) together. This
diﬀerential signal is averaged over 12 experiments and charted (3 repeats of HIV+, RAM+, combination, and negative control experiments). (D)
Images and bar charts displaying data acquired from the chip. There are four possible diﬀerent outcomes of HIV/RAM multiplexed assay. If the
rabbit serum sample contains HIV rabbit antibodies, the HIV area develops a dark spot, if it contains rabbit anti-mouse (RAM) antibodies, then the
RAM area develops a dark spot. Typically 10−30 pixels are averaged to calculate the signal level of a printed/control area. The contrast of these
grayscale images was enhanced for illustration purposes.
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Figure 4A shows the outcome of the HIV assay when the
antibodies in the analyte were present (HIV+), absent (HIV-),
and when the gp120 capture protein on the surface is absent
(BSA-). Figure 4B,C shows the outcome of the HIV assay when
the concentration of the printed HIV gp120 antigen or the
rabbit anti-gp120 antibody was varied. These graphs can be
used to determine the minimum concentration of printed
antigen required, as well as the minimum detectable
concentration of anti-gp120 antibody. Figure 4B represents 2
separate runs of experiments with 4 droplets printed for each
data point. Figure 4C represents a single run of experiments
with 2 droplets printed for each data point (since this assay was
repeated with ﬁxed concentrations many times, no further
repeats were deemed necessary).
Figure 4D,E shows results of the positive control (rabbit
IgG) assays with two parameters varied. These experiments
serve two purposes. They demonstrate the eﬀects that reagent
concentrations and development time have on the outcome.
They also indicate the minimum required concentrations and
time needed to detect antibodies.
Figure 4D shows the outcome of the positive control
experiment as the silver development time is varied to
determine the minimum amount of time required for the
silver to develop on positive control areas. The assay needs at
least 10 min to produce a signiﬁcant diﬀerence between
positive and negative control areas. Accordingly, 15 min was
chosen as the minimum amount of development time that
guarantees a successful positive control. F̀igure 4D represents 5
droplets for each data point acquired from two separate runs of
the experiment.
Figure 4E shows how the outcome of a positive control
experiment changes when varying the secondary gold
conjugated antibody concentration. The assay starts working
at a dilution of 1:100 (A520 = 0.05) and continues to improve as
the concentration goes up. A 1:50 dilution (A520 = 0.1) was
chosen to ensure suﬃcient antibody is present to indicate a
positive result without using an excessive amount of reagent,
which has an economic beneﬁt. Figure 4E represents a single
run of assays, 3 droplets were printed for each data point (since
this assay was repeated with ﬁxed concentrations many times,
no further repeats were deemed necessary).
■ MATERIALS AND METHODS
CMOS Sensor Chip. The sensor chip used in this work
incorporates an array of 16 × 16 pixels. Each pixel incorporating a
p−n junction photodiode with three transistors for readout.22 The
chip uses a global shutter scheme for exposure and a scanning scheme
for acquisition where one 4-bit row decoder and one 4-bit column
decoder are integrated outside the active area.
The chip measures 3.4 mm × 3.6 mm and was fabricated using the
AMS 0.35 μm CMOS process. The chip was designed so its wire
bonds are only on two sides of the chip. This allows easy access to the
surface of the chip. For our work we used a custom designed
photodiode array since commercially available devices are packaged in
such a way that they inhibit experimentation. In the future, commercial
chips could be used.
Figure 4. Assay characteristics on polystyrene (A−E) and glass (F). (Data acquisition system was connected to a PC.) (A) Result of two negative
control assays and an HIV+ assay were measured by the photodiode array. The HIV- assay is an HIV assay where the anti-gp120 antibody was
substituted with IgG solution to simulate a negative sample, whereas the BSA- assay lacks the HIV capture protein (gp120) on the surface, so the
anti-gp120 antibody in the analyte has nothing to bind to. (B) HIV antibody concentration of the HIV+ assay was varied. (C) Printed HIV antigen
concentration of the HIV+ assay was varied. (D) Silver development time of the positive control assay was varied. (E) Concentration of the gold
conjugated antibody solution of the positive control assay was varied. (A520 is a measure of light absorbance at 520 nm which is directly
proportional to the concentration of gold conjugated antibodies). (F) Transmission spectrum of a silver spot developed on an SU-8 covered glass
slide, showing wavelength independence. Measured using a spectrophotometer. (A−E) Default parameters: 10 μg/mL gp120, 100 μg/mL rabbit
anti-gp120, 15 min silver development.
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Chip Packaging. The bond wires and parts of the chip were
protected from aqueous reagents and cleaning solutions (Figure 1A,B).
The chip was mounted on a chip carrier using epoxy (EPO-TEK
H74). The epoxy was cured at 150 °C for 10 min. The chip was then
wire bonded to the chip carrier. Polydimethylsiloxane (PDMS)
cuboids were used to cover the chip sensor area and to make a channel
leading to the edges of the chip carrier. Next, epoxy resin (EPO-TEK
302-3M) was applied to the bond wires and bond pads. The PDMS
cuboids prevented epoxy from covering the surface of the sensor array.
The epoxy was cured at room temperature for 24 h. Then the chip was
covered with SU-8 3005 photoresist and spun at 1500 rpm for 30 s.
The channel leading to the edge of the chip carrier allows the excess
resist to escape the surface of the chip while spinning. The resist was
cured with heat and UV radiation (90 °C oven for 1 h, 200 mJ/cm2
UV). The resulting layer of SU-8 was approximately 10 μm thick.
Once the immunoassay was executed on the surface of the chip, the
SU-8 resist layer, along with any biological material was stripped using
piranha solution (3:1 sulfuric acid and hydrogen peroxide, 3−15 min).
Some chips were reused (with a fresh coat of SU-8) until defects were
detected. As a medical device these chips are meant to be single use, so
the parameters of reusability were not investigated further.
Chemicals and Reagents. Phosphate buﬀered saline (PBS),
bovine serum albumin (BSA), bicarbonate buﬀer, rabbit IgG, anti-
mouse rabbit IgG, mouse IgG, rabbit serum, rabbit anti-gp120
antibody, 10 nm gold conjugated goat anti-rabbit IgG, silver nitrate,
citric acid, trisodium citrate dehydrate, and hydroquinone were
obtained from Sigma-Aldrich Co., UK. Recombinant HIV gp120
antigen was obtained from Fisher Scientiﬁc UK Ltd.
HIV gp120 antigen solution was prepared using 10 μg/mL gp120 in
bicarbonate buﬀer. Rabbit IgG solution was prepared using 10 μg/mL
rabbit IgG in bicarbonate buﬀer. 1% BSA blocking buﬀer was prepared
using PBS. The HIV/RAM test antibody solution was made up of 100
μg/mL rabbit anti-gp120 and/or anti-mouse rabbit antibody in PBS
and rabbit serum (35−65%). Gold conjugated anti-rabbit IgG stock
solution was diluted 1:50 using 3% BSA solution. Silver developer
solution was prepared fresh before use containing 500 μg/mL silver
nitrate and 17 mg/mL hydroquinone using citrate buﬀer. Citrate buﬀer
was prepared containing 2.35% citric acid and 2.55% trisodium citrate.
All solutions were prepared with Millipore water.
Immunoassay Procedure. The CMOS chip was coated with 10-
μm-thick SU-8 photoresist. HIV antigen solution and mouse IgG
solution was spotted on the surface of the chip using polystyrene
inoculation needles (Fisher Scientiﬁc Ltd.). The spots were incubated
at room temperature in a sealed, humid container for an hour. The
chip was rinsed with PBS and water, covered with blocking buﬀer, and
incubated for an hour. The chip was then rinsed and covered with
HIV/RAM test antibody serum solution for 10 min, then rinsed again
and covered with gold conjugated antibody solution for 10 min. After
rinsing, the chip was covered with developer solution and incubated
for 25 min under a dark cover. The resulting structure is illustrated in
Figure 2. Finally, the chip was rinsed in water, dried, and inserted into
the data acquisition system. A blue LED (VLMB1300-GS08) was used
to illuminate the surface of the chip. The brightness was adjusted to
achieve optimal illumination (PD output 1−2.5 V, diﬀerent chips
needed diﬀerent brightness). Each photodiode in the array produced a
voltage depending on the amount of light that reached it.
■ CONCLUSION
Two localized silver staining assays that function essentially as
an ELISA presented in ref 17 were successfully integrated and
multiplexed on the surface of a CMOS sensor array. The
advantages of running assays directly on the surface of a sensor
array are manifold. The average of multiple sensors can be used
to reliably evaluate a single assay, and, crucially, multiple assays
can be executed concurrently on the surface of a single chip.
The approach also allows wash steps that increase sensitivity
and speciﬁcity when compared to popular paper based lateral
ﬂow immunoassays. This is the ﬁrst step in creating a mass-
manufacturable hand-held point-of-care (POC) personal
diagnostic tool capable of performing all necessary medical
tests in one device.
The results presented show that the positive HIV assay, as
well as the RAM assay, produce a signal comparable to the
positive control. Furthermore, the assays on top of an SU-8
covered CMOS chip produce similar signals to those generated
using polystyrene plates, the current gold standard for ELISA
assays. The concentration of the HIV antibody used here is
three times lower than reported in typical human infections
(300−500 μg/mL);11 hence, this assay would be suitable to
detect HIV antibodies in human blood. It is also demonstrated
that multiple assays can be performed concurrently in the same
solution without these assays interfering with each other. Here,
we have shown that antibodies speciﬁc to HIV gp120 and
antibodies speciﬁc to mouse IgG are simultaneously identiﬁed.
Next we will extend the array of detected antigens to a range of
other pathogens.
Signal strength can also be controlled by varying parameters
such as reagent concentration and development time, and as we
scale the device to include additional pathogen detection
immunoassyas, we will optimize conditions appropriately.
Both a PC-based and a smartphone-based data acquisition
system were designed and evaluated. The USB OTG connected
smartphone app is excellent for reliably acquiring high-speed
data surpassing the PC based system in both speed and
reliability. This proves that the concept of a complex hand-held
diagnostic device is only a few steps away.
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A.; Maxwell, E. J.; Fernańdez-Abedul, M. T.; Whitesides, G. M.
Universal Mobile Electrochemical Detector Designed for Use in
Resource-Limited Applications. Proc. Natl. Acad. Sci. U. S. A. 2014, 111
(33), 11984−11989.
(9) Lee, D.-S.; Jeon, B. G.; Ihm, C.; Park, J.-K.; Jung, M. Y. A Simple
and Smart Telemedicine Device for Developing Regions: A Pocket-
Sized Colorimetric Reader. Lab Chip 2011, 11 (1), 120−126.
(10) Laksanasopin, T.; Guo, T. W.; Nayak, S.; Sridhara, A. A.; Xie, S.;
Olowookere, O. O.; Cadinu, P.; Meng, F.; Chee, N. H.; Kim, J.; et al. A
Smartphone Dongle for Diagnosis of Infectious Diseases at the Point
of Care. Sci. Transl. Med. 2015, 7 (273), 273re1.
(11) Greenﬁeld, E. A. Antibodies: A Laboratory Manual, 2nd ed.; Cold
Spring Harbor Laboratory Press, 2014.
(12) Binley, J. M.; Klasse, P. J.; Cao, Y.; Jones, I.; Markowitz, M.; Ho,
D. D.; Moore, J. P. Differential Regulation of the Antibody Responses
to Gag and Env Proteins of Human Immunodeficiency Virus Type 1. J.
Virol. 1997, 71 (4), 2799−2809.
(13) Rychert, J.; Strick, D.; Bazner, S.; Robinson, J.; Rosenberg, E.
Detection of HIV gp120 in Plasma during Early HIV Infection Is
Associated with Increased Proinflammatory and Immunoregulatory
Cytokines. AIDS Res. Hum. Retroviruses 2010, 26 (10), 1139−1145.
(14) Klasse, P. J.; Moore, J. P. Is There Enough gp120 in the Body
Fluids of HIV-1-Infected Individuals to Have Biologically Significant
Effects? Virology 2004, 323 (1), 1−8.
(15) Irvine, E. J.; Hernandez-Santana, A.; Faulds, K.; Graham, D.
Fabricating Protein Immunoassay Arrays on Nitrocellulose Using Dip-
Pen Lithography Techniques. Analyst 2011, 136 (14), 2925.
(16) Joh, D. Y.; Hucknall, A. M.; Wei, Q.; Mason, K. A.; Lund, M. L.;
Fontes, C. M.; Hill, R. T.; Blair, R.; Zimmers, Z.; Achar, R. K.; et al.
Inkjet-Printed Point-of-Care Immunoassay on a Nanoscale Polymer
Brush Enables Subpicomolar Detection of Analytes in Blood. Proc.
Natl. Acad. Sci. U. S. A. 2017, 114 (34), E7054−E7062.
(17) Plate, D. K. Group, on behalf of the R. H. T. E. W. Evaluation
and Implementation of Rapid HIV Tests: The Experience in 11
African Countries. AIDS Res. Hum. Retroviruses 2007, 23 (12), 1491−
1498.
(18) Delaney, K. P.; Branson, B. M.; Uniyal, A.; Phillips, S.; Candal,
D.; Owen, S. M.; Kerndt, P. R. Evaluation of the Performance
Characteristics of 6 Rapid HIV Antibody Tests. Clin. Infect. Dis. 2011,
52 (2), 257−263.
(19) Kagulire, S. C.; Opendi, P.; Stamper, P. D.; Nakavuma, J. L.;
Mills, L. A.; Makumbi, F.; Gray, R. H.; Shott, J. P.; Serwadda, D.;
Reynolds, S. J. Field Evaluation of Five Rapid Diagnostic Tests for
Screening of HIV-1 Infections in Rural Rakai, Uganda. Int. J. STD
AIDS 2011, 22 (6), 308−309.
(20) Lackie, P. M. Immunogold Silver Staining for Light Microscopy.
Histochem. Cell Biol. 1996, 106 (1), 9−17.
(21) Deegan, R. D.; Bakajin, O.; Dupont, T. F.; Huber, G.; Nagel, S.
R.; Witten, T. A. Capillary Flow as the Cause of Ring Stains from
Dried Liquid Drops. Nature 1997, 389 (6653), 827−829.
(22) Fossum, E. R. CMOS Image Sensors: Electronic Camera-on-a-
Chip. IEEE Trans. Electron Devices 1997, 44 (10), 1689−1698.
ACS Sensors Article
DOI: 10.1021/acssensors.7b00972
ACS Sens. 2018, 3, 953−959
959
